ASSESSING THE QUALITY OF LIFE OF WOMEN OF REPRODUCTIVE AGE AFTER TREATMENT OF UTERINE FIBROIDS WITH ANTIGESTAGENS

Abstract

The objective is to assess the quality of life of patients with uterine myoma after various treatment options.Today, conservative treatment of uterine myoma with the help of mifepristone is gaining popularity. The indicators of the quality of life of women in the three groups before and after treatment are analyzed. Group 1 (n = 38) - laparoscopic conservative myomectomy without subsequent anti-relapse drug therapy; Group 2 (n = 43) - laparoscopic conservative myomectomy followed by an-ti-relapse drug therapy - mifepristone at a dose of 50 mg daily from the 2nd day of the menstrual cycle for 3 months; Group 3 (n =36) - drug monotherapy - mifepristone in a dose of 50 mg daily from 2nd day of the menstrual cycle for 3 months. As a result, it was noted that after treatment, indicators of physical and role functioning, due to both physical and emotional state, were higher in groups 2 and 3. Thus, mifepristone positively affects the quality of life of patients with myoma, as in the case of combined treatment, and in the form of monotherapy.